Education
About Us
Working with TipRanks
Follow Us
NDT Pharmaceuticals, Inc. (NDTP)
OTHER OTC:NDTP
| Dec 23 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 0.00 |
| Gross Profit | $ 0.00 |
| Operating Income | $ -25.17K |
| EBITDA | $ 88.87K |
| Net Income | $ -79.03K |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 647.00 |
| Total Assets | $ 142.97K |
| Total Debt | $ 0.00 |
| Net Debt | $ -647.00 |
| Total Liabilities | $ 41.80K |
| Stockholders' Equity | $ 101.17K |
| Cash Flow | |
| Free Cash Flow | $ -17.76K |
| Operating Cash Flow | $ -17.76K |
| Investing Cash Flow | $ 0.00 |
| Financing Cash Flow | $ 17.76K |
NDT Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.